In the BioHarmony Drug Report Database

"Preview" Icon

Posaconazole

Noxafil (posaconazole) is a small molecule pharmaceutical. Posaconazole was first approved as Noxafil on 2005-10-25. It is used to treat mycoses and oral candidiasis in the USA. It has been approved in Europe to treat aspergillosis, candidiasis, coccidioidomycosis, and mycoses. Noxafil’s patents are valid until 2033-02-27 (FDA).

 

Trade Name

 

Noxafil
 

Common Name

 

posaconazole
 

ChEMBL ID

 

CHEMBL1397
 

Indication

 

aspergillosis, candidiasis, coccidioidomycosis, mycoses, oral candidiasis
 

Drug Class

 

Systemic antifungals (miconazole type)

Image (chem structure or protein)

Posaconazole structure rendering